Table 2 Known prognostic parameters and semiquantitative measures according to necrosisvisual status.
Total (n = 71) | Necrosisvisual status | |||||
|---|---|---|---|---|---|---|
Absent (n = 58) | Present (n = 13) | |||||
No. | % | No. | % | No. | % | |
Stage | ||||||
I-II | 43 | 60.6 | 35 | 60.3 | 8 | 61.5 |
III-IV | 28 | 39.4 | 23 | 39.7 | 5 | 38.5 |
IPS† | ||||||
0–2 (low risk) | 50 | 70.4 | 42 | 72.4 | 8 | 61.5 |
3–7 (interm./high risk) | 20 | 28.2 | 15 | 25.9 | 5 | 38.5 |
Bulky disease | ||||||
No | 54 | 76.1 | 49 | 84.5 | 5 | 38.5 |
Yes | 17 | 23.9 | 9 | 15.5 | 8 | 61.5 |
SUVmax | ||||||
Median (range) | 7.1 (3.4–20.9) | 7.0 (3.4–21.0) | 7.9 (5.4–18.3) | |||
SUVmean | ||||||
Median (range) | 4.2 (2.7–8.7) | 4.2 (2.7–8.7) | 4.2 (3.3–8.2) | |||
SUVpeak | ||||||
Median (range) | 5.3 (2.7–17.1) | 5.3 (2.7–17.1) | 5.3 (4.1–15.7) | |||
MTV | ||||||
Median (range) | 237.8 (3.8–1212) | 206.7 (3.8–1212) | 398.7 (56.9–1151) | |||
TLG | ||||||
Median (range) | 1169 (12.1–8048) | 1093 (12.1–5775) | 2079 (346–8048) | |||
